Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

heparin calcium

Known as: calcium heparin [Chemical/Ingredient], heparin-calcium, calcium heparinate 
The calcium salt form of heparin. As a glycosaminoglycan anticoagulant, heparin calcium binds to antithrombin III to form a heparin-antithrombin III… Expand
National Institutes of Health

Related topics

Related topics

17 relations
Angina, UnstableCerebral InfarctionCoronary ThrombosisDisseminated Intravascular Coagulation
Expand

Broader (2)

AnticoagulantsFibrinolytic Agents

Narrower (1)

Calciparine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
Subcutaneous Heparin Versus Low-Molecular-Weight Heparin as Thromboprophylaxis in Patients Undergoing Colorectal Surgery: Results of the Canadian Colorectal DVT Prophylaxis Trial: A Randomized…
ObjectiveTo compare the effectiveness and safety of low-dose unfractionated heparin and a low-molecular-weight heparin as… Expand
Highly Cited
1999
Highly Cited
1999
Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin…
BACKGROUND Cardiopulmonary bypass (CPB) induces platelet activation with release of platelet factor 4 (PF4), and patients are… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Highly Cited
1995
Highly Cited
1995
Use of recombinant hirudin as antithrombotic treatment in patients with heparin‐induced thrombocytopenia
Heparin‐induced thrombocytopenia is a rare but severe complication of heparin therapy that can result in severe venous or… Expand
Highly Cited
1991
Highly Cited
1991
Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin.
OBJECTIVE To determine the relative efficacy and safety of low molecular weight (LMW) heparin (Enoxaparin) compared with standard… Expand
Highly Cited
1988
Highly Cited
1988
Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.
A double blind randomized trial comparing subcutaneous enoxaparin (40 mg once daily) with standard unfractionated calcium heparin… Expand
Highly Cited
1988
Highly Cited
1988
Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery
In a prospective, randomized multicentre trial the efficacy and safety of the low molecular weight heparin (LMWH) fraction… Expand
Highly Cited
1987
Highly Cited
1987
Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial.
STUDY OBJECTIVE To determine the efficacy and safety of adjusted subcutaneous calcium heparin compared with continuous… Expand
Highly Cited
1986
Highly Cited
1986
Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke.
Venous thrombo-embolism is a major and often unrecognized cause of morbidity and mortality in patients after acute strokes. Three… Expand
Highly Cited
1985
Highly Cited
1985
Efficacy and safety of low‐molecular‐weight heparin (CY216) in preventing postoperative venous thrombo‐embolism: A co‐operative study
The efficacy and safety of a low‐molecular‐weight (LMW) heparin fraction in preventing postoperative venous thrombo‐embolism, was… Expand
Highly Cited
1979
Highly Cited
1979
Prophylaxis for postoperative deep-vein thrombosis. Synergistic effect of heparin and dihydroergotamine.
Randomized clinical trials in 300 patients undergoing major abdominal surgery or hip replacement arthroplasty were performed to… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE